Correction for: circUBAP2 exacerbates malignant capabilities of NSCLC by targeting KLF4 through miR-3182 modulation

Aging (Albany NY). 2022 Mar 14;14(5):2432-2433. doi: 10.18632/aging.203928. Epub 2022 Mar 14.

Authors

Guanying Zheng¹, Jianyuan Huang², Wenshu Chen², Peilin You², Yun Ding², Pengjie Tu²

Affiliations

¹ Department of Pulmonary and Critical Care Medicine, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fuzhou 350001, Fujian Province, China.
² Department of Thoracic Surgery, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fuzhou 350001, Fujian Province, China.

No abstract available

Keywords: NSCLC; chemo-resistance; circUBAP2; therapeutic target.

Publication types

Published Erratum